Denosumab 60mg/mL (r-DNA origin) in Pre-Filled Syringe

Send Inquiry

Request To Call Back

Denosumab 60mg/mL (r-DNA origin) in Pre-Filled Syringe

Name: Denosumab 60mg/mL (r-DNA origin) in Pre-Filled Syringe
Brand: K. K. PHARMA SOLUTIONS
Price: 12000 INR
Availability: InStock

Price 12000 INR/ Unit

Get a Price/Quote

MOQ : 10 Units

Denosumab 60mg/mL (r-DNA origin) in Pre-Filled Syringe Specification

Indication
Treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, bone loss due to hormone ablation, prevention of skeletal-related events

Dosage Form
Injection

Origin of Medicine
Biotechnology (r-DNA origin)

Salt Composition
Denosumab 60mg/mL

Pacakaging (Quantity Per Box)
1 Pre-Filled Syringe per box

Drug Type
Injection

Ingredients
Denosumab (r-DNA origin)

Physical Form
Liquid Solution

Function
Monoclonal antibody for bone density improvement and prevention of fractures

Recommended For
Adults with osteoporosis and other conditions with increased bone resorption

Dosage
60mg per mL

Dosage Guidelines
As directed by a physician

Suitable For
Adults

Storage Instructions
Store in a refrigerator (2C 8C). Do not freeze. Protect from light.

Denosumab 60mg/mL (r-DNA origin) in Pre-Filled Syringe Trade Information

Minimum Order Quantity
10 Units

Supply Ability
100 Units Per Week

Delivery Time
7 Days

About Denosumab 60mg/mL (r-DNA origin) in Pre-Filled Syringe

Each pre-filled syringe contains 60 mg of denosumab in 1 mL of solution (60 mg/mL).Denosumab is a human monoclonal IgG2 antibody produced in a mammalian cell line (Chinese hamster ovary cells) by recombinant DNA technology. This medicine contains 47 mg sorbitol in each mL of solution.

Powerful Monoclonal Antibody for Bone Health

Denosumab 60mg/mL acts as a targeted monoclonal antibody, effectively inhibiting RANKL activity. This mechanism curtails osteoclast-mediated bone resorption, helping restore bone strength and decrease the likelihood of fractures, particularly in individuals with osteoporosis or those undergoing hormone ablation treatments.

User-Friendly Pre-Filled Syringe Design

Designed for ease of administration, the product comes in a single-use, pre-filled glass syringe complete with an attached needle. This reduces preparation steps and maximizes safety, making subcutaneous self-administration or physician-assisted injection straightforward and reliable.

Reliable and Long Shelf Life

Each Denosumab pre-filled syringe maintains its stability and potency when stored between 2C and 8C, avoiding freezing and direct light exposure. With a 24-month shelf life from the manufacturing date, the product offers extended usability and flexible storage options for both clinics and patients.

FAQs of Denosumab 60mg/mL (r-DNA origin) in Pre-Filled Syringe:

Q: How is Denosumab 60mg/mL administered to patients?

A: Denosumab is delivered by subcutaneous injection using a single-use, pre-filled glass syringe with an attached needle. It should be administered by a healthcare professional or as directed by your physician.

Q: What is the primary benefit of using Denosumab for osteoporosis?

A: Denosumab inhibits RANKL, which reduces osteoclast cell activity and bone resorption. This action helps strengthen bones, lowers the risk of fractures, and improves overall bone density in adults, especially postmenopausal women and men at increased risk.

Q: When should Denosumab 60mg/mL injections be given?

A: The timing and frequency of Denosumab injections should be determined by your physician, typically administered at regular intervals, such as once every six months, based on individual patient needs and treatment goals.

Q: Where should Denosumab 60mg/mL be stored prior to use?

A: Store Denosumab in a refrigerator at a temperature between 2C and 8C. Avoid freezing and protect the syringe from light to preserve the efficacy and safety of the medication.

Q: What process does Denosumab use to improve bone health?

A: Denosumab works by binding to RANKL, a protein responsible for stimulating bone-resorbing cells called osteoclasts. By blocking RANKL, the medication suppresses bone breakdown and promotes bone density improvement.

Q: Is Denosumab suitable for self-administration?

A: The pre-filled syringe with an attached needle is designed for convenient use. However, it should only be self-administered after proper training or as directed by a healthcare professional to ensure safety and correct technique.

Q: Who should use Denosumab 60mg/mL injection?

A: Denosumab is recommended for adults, particularly postmenopausal women and men with osteoporosis, those at increased risk of bone fracture, or individuals experiencing bone loss due to hormone ablation. Always use under medical supervision.

Tell us about your requirement